V804M RET mutation and familial medullary thyroid carcinoma: Report of a large family with expression of the disease only in the homozygous gene carriers

Surgery

Volumn 131, Issue 5, 2002, Pages 509-514

  Lecube, Albert ^a,b   Hernandez, Cristina ^a,b   Oriola, Josep ^a,b   Galard, Rosa ^a,b   Gémar, Enrique ^a,b   Mesa, Jorge ^a,b   Simó, Rafael ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PENTAGASTRIN; PROTEIN RET;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; CELL HYPERPLASIA; CHILD; CONSANGUINEOUS MARRIAGE; DISEASE COURSE; FAMILIAL CANCER; FAMILY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HISTOLOGY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTO ONCOGENE; PROVOCATION TEST; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

EID: 0036255690     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.123006     Document Type: Article

References (27)

1. Analysis of RET proto-oncogene point mutations distinguishes heritable from non-heritable medullary thyroid carcinomas
2. RET receptor tyrosine kinase gene mutations: Molecular biological, physiological and clinical aspects
3. Specific mutation of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC
4. Genotype-phenotype correlation in MEN type 2: Report of the International RET Mutation Consortium
5. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2
6. Novel point mutation in exon 10 of the RET proto-oncogene in a family with medullary thyroid carcinoma
7. Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?
8. A novel point mutation in the tyrosine kinase domain of the RET proto-oncogene in sporadic medullary thyroid carcinoma and in a family with FMTC
9. A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma
10. Mutation of RET codon 768 is associated with the FMTC phenotype
11. A new hot spot for mutations in the ret proto-oncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A
12. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation
13. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene
14. A GTG to ATG novel point mutation at codon 804 in exon 14 of the RET proto-oncogene in two families affected by familial medullary thyroid carcinoma
15. Germline V804M mutation in the RET proto-oncogene in two apparently sporadic cases of MTC presenting in the seventh decade of life
16. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG → ATG) mutation
17. Update on the MEN 2A c804 RET mutation: Is prophylactic thyroidectomy indicated?
18. A simple salting out procedure for extracting DNA from human nucleated cells
19. Analysis of the VNTR locus DIS80 by the PCR folowed by high-resolution PAGE
20. Modification of enzymatically amplified DNA for the detection of point mutations
21. Management of individual tumor syndromes: Medullary thyroid carcinoma and hyperparathyroidism
22. C-cell populations in normal children in young adults
23. Age-associated C-cell hyperplasia in the human thyroid
24. Endocrine changes associated with the human aging process: Effect of age on the number of calcitonin inmunoreactive cells in the thyroid gland
25. False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A
26. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: Comparison with genetic screening in hereditary medullary thyroid carcinoma
27. Prophylactic thyroidectomy in MEN 11A: Does the calcitonin level correlate with the tumor spread?